Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05169333 · ClinicalTrials.gov registry record
The Oxford Risk Factors And Non-Invasive Imaging Study
A clinical trial of Cardiovascular Diseases and Cardiovascular Risk Factors, sponsored by University of Oxford.
- Recruiting
- Registry status
- 250,000
- Enrollment target
- 20
- Study locations
NCT05169333 is a study of Cardiovascular Diseases and Cardiovascular Risk Factors that is actively recruiting participants, run by University of Oxford. The registered enrollment target is 250,000 participants, above the 26,141-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (856% higher). The trial reports 20 study locations across 4 states.
The verdict
NCT05169333, a study of Cardiovascular Diseases and Cardiovascular Risk Factors, is actively recruiting participants, sponsored by University of Oxford.
- RECRUITING
- Registry status
- 250,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Conditions Studied
Study Locations (20)
Other
- Flinders University - Adelaide
- The University of Sydney - Sydney
- University Hospitals Leuven - Leuven
- Fudan University - Shanghai
- TEDA International Cardiovascular Hospital - Tianjin
- Almaviva Sante - Clinique Axium - Aix-en-Provence
- Friedrich-Alexander-Universitat Erlangen-Nurmberg - Erlangen
- University Hospital Ulm - Ulm
- Lefkos Stavros Clinic - Athens
- MTA-SE Cardiovascular Imaging Research Group - Budapest
- Centro Cardiologico Monzino IRCCS, University of Milan - Milan
- Oita University - Ōita
- Amsterdam Universitair Medische Centra - Amsterdam
- Zuyderland Medical Centre - Sittard
- University of Medicine and Pharmacy of Targu Mures - Târgu Mureş
- Seoul National University - Seoul
- Cleveland Clinic Abu Dhabi - Abu Dhabi
Maryland
- NIH National Heart, Lunch, and Blood Institute - Bethesda
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic Heart and Vascular Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250,000 participants |
| Start Date | 2016-02-23 |
| Est. Completion | 2030-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05169333
The ClinicalTrials.gov registry entry for NCT05169333 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 26,141-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (856% higher). The listed sponsor is University of Oxford, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05169333 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Other, Maryland, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05169333 about?
NCT05169333 is a clinical study titled "The Oxford Risk Factors And Non-Invasive Imaging Study". ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
What is the current status of trial NCT05169333?
This trial is currently recruiting. The enrollment target is 250,000 participants. The study started on 2016-02-23. Estimated completion is 2030-02.
What conditions does trial NCT05169333 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiovascular Risk Factors.
Who is sponsoring clinical trial NCT05169333?
This trial is sponsored by University of Oxford, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05169333 being conducted?
This trial has 20 study locations across Maryland, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.